Malignant teratoma
Information, Symptoms, Treatments and Resources
Malignant teratoma is a type of cancer that involves cysts that contain one or more of the three main types of cells found in a developing baby (embryo). These cells are callled ectoderms, mesoderms, and endoderms.
Dermoid cyst - malignant; Nonseminomatous germ cell tumor - teratoma; Immature teratoma
Malignant teratoma occurs most often in young men in their 20's - 30's. It is often located in the anterior mediastinum (in the chest). Most malignant teratomas have spread (metastasized) by the time of diagnosis and they can spread throughout the body.
A number of other cancers are often associated with these tumors including:
- Acute myelogenous leukemia (AML)
- Myelodysplasia (MDS)
- Malignant histiocytosis
- Embryonal rhabdomyosarcoma
- Small cell undifferentiated carcinoma
Symptoms result from spread of the tumor into surrounding tissues and include:
- Cough
- Shortness of breath
- Chest pain
- Limited exercise tolerance
- Fatigue
On physical examination, a physician may see signs of congestive heart failure and increased pressure in the chest cavity. Diagnosis is made using the following tests:
- History and physical examination
- CT scans of the chest, abdomen, and pelvis
- Elevated levels of b-HCG and AFP in the blood
- Mediastinoscopy and biopsy -- use of a special scope to look in the mediastinum (mediastinoscopy) and remove a piece of the tumor (biopsy)
- Anterior mediastinotomy -- open surgery to remove the tumor or part of it
Because malignant teratomas have often spread by the time of diagnosis, anticancer chemotherapy is usually needed. Cisplatin, etoposide, and bleomycin are commonly used as a combination of chemotherapy.
After chemotherapy is complete, CT scans are repeated. If there is a residual mass in the area of the tumor, surgery is recommended because of the possibility that the cancer will grow back in that area.
The prognosis for people with malignant teratomas is based on the size of the tumor, its location, and the age of the patient. In young patients, less than 15 years of age, teratomas are more likely to be benign. For adults, complete remission is possible in 50 - 70% of patients, and about 42% will see long-term survival.
The cancer can spread throughout the body and there may be complications of surgery or related to chemotherapy.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. � 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
